UBS Wealth Arm Looks for Pullback in Japan Stocks Before Buying
An asset management titan is waiting for a pullback in Japanese stocks before stepping in to buy. UBS
2023-07-19 07:27
Sunak’s Popularity Sinks to Lowest Since UK Premier Took Power
Rishi Sunak’s popularity rating sank to its lowest level since he became UK prime minister in October, highlighting
2023-07-19 07:25
Rio Tinto Iron Ore Shipments Dip as It Faces China Headwinds
Rio Tinto Group, the world’s top iron ore producer, said second-quarter shipments of the steelmaking ingredient fell 1%
2023-07-19 07:16
Crowdfunded Real Estate Deals Unravel as Funds Vanish
Hundreds of regular investors who together put up $63 million to buy pieces of Atlanta and Miami commercial
2023-07-19 06:46
North Korea Tests Missiles After US Nuclear Sub Sails to South
North Korea launched two missiles into waters off its east coast in a show of anger hours after
2023-07-19 06:16
Thai PM Hopeful Pita Awaits Parliament Debate on Eligibility for Re-Nomination
Thai politician Pita Limjaroenrat will Wednesday renew his attempt to win parliament’s support to become the country’s next
2023-07-19 06:15
Western Alliance Sees Higher Costs on Deposits, Borrowings
Western Alliance Bancorp reeled in more deposits in the second quarter — at a cost. The bank’s interest
2023-07-19 05:59
AT&T Says Less Than 10% of Its Network Has Lead Covered Cables
AT&T Inc. says less than 10% of its nationwide copper-wire telecom network has lead-clad cables, addressing investor concerns
2023-07-19 05:58
DeSantis Says He Hopes Trump Isn’t Charged in Jan. 6 Investigation
Ron DeSantis stopped short of criticizing his chief rival for the Republican presidential nomination, Donald Trump, or staking
2023-07-19 05:55
SEC Declines to Share View on Leveraged Loan Securities Suit
The Securities and Exchange Commission said it is “not in a position to file” a brief giving its
2023-07-19 05:48
Trump Trial Date in Documents Case Is Up in the Air for Now
A federal judge in Florida didn’t immediately set a trial date in the classified documents prosecution against Donald
2023-07-19 04:46
Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
2023-07-19 04:17